Axon workstation wins R&D award
Thursday, 31 July, 2003
ASX-listed Axon Instruments has picked up an R&D 100 award for its OpusExpress 6000A electrophysiology workstation.
The awards, which recognise the 100 most innovative new technologies of the previous 12 months, is made by the editors of R&D Magazine and a panel of independent judges.
Axon's OpusExpress system is described by the company as the first commercially available multi-channel, automated oocyte voltage-clamp recording system, which makes possible high-throughput electrophysiology and improves the efficiency of the drug discovery process.
In a statement, Axon CEO Alan Finkel said high-throughput electrophysiology was the wave of the future.
"It is changing the way that pharmaceutical companies search for ion-channel drugs," Finkel said.
Ion channels have been implicated in a number of diseases, including cystic fybrosis, epilepsy, muscular dystrophy, migraine and cancer. The Human Genome project identified between 300 and 400 ion-channel genes in humans.
Hormone therapy shifts body proteins to match gender identity
Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...
Targeting 'molecular bodyguards' weakens prostate cancer cells
Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...
Females found to carry a higher genetic risk of depression
An international team of scientists has discovered about twice as many genetic 'flags'...
